PPT-Direct-to-Consumer Genetic Testing

Developed by Ms Shawna Morrison Dr June Carroll and Dr Judith Allanson Last updated May 2016 Disclaimer This presentation is for educational purposes only and should not be used as a substitute for clinical judgement GECKO aims to aid the practicing clinician by providing informed opinions regarding genetic services that have been developed in a rigorous and evidencebased manner Physicians must use their own clinical judgement in addition to published articles and the information presented herein GECKO assumes no responsibility or liability resulting from the use of information contained herein . : ELSI and the Direct-to-Consumer Genetic Testing Space. Jan Charbonneau, Dianne Nicol & Don Chalmers. Centre for Law & Genetics, University of Tasmania. This research has three main components. Inbal. . Livni. Navon. Weizmann Institute. Direct product operation. Basic operation on functions. Useful for hardness amplification “one new instance is as hard as k”.  . Testing direct products. Risks and Benefits of Knowing Your Genetic Makeup. Julie Hopp. Genetic Screening: Who Should Be Tested. CDC’s 2004 Science Ambassador Program. Overview. Genetics Review. Types of Genetic Disorders. Ben Ho Park MD PhD. Johns Hopkins University. Financial Disclosures. I have financial relationships with commercial entities that are relevant to the content of this presentation.. Royalties from Horizon Discovery, LTD. Who is Genetic Services?. Administrative Staff . Genetic Counsellors. Clinical Geneticists. Registries (Familial Cancer). Research Nurses . Laboratories. Clinical staff divided into three. different areas:. Issues. Types of tests being sold. Diagnostic tests – identify specific conditions. Carrier testing - identify those who carry a mutation that if present in two copies causes a genetic disorder.. Ancestry Testing – ethnic background. For educational purposes but not medical. How common are BRCA1 and BRCA2 mutations in the general population? Inherited mutations in BRCA1 and BRCA2 are relatively uncommon in the general population. The carrier frequency is estimated to rang Patients in the Hereditary Cancer Network Database Background: Mutations in BRCA1 and BRCA2 genes increase an individual’s lifetime risk of breast cancer up to 80 percent, ovarian cancer up to 3 Huntington Society of Canada 151 Frederick St., Suite 400, Kitchener ON N2H 2M2 1-800-998-7398 info@huntingtonsociety.ca www.huntingtonsociety.ca Charitable Registration Number 11896 5516 RR0001 Wh Page 1 of 28 UnitedHealthcare Commercial Medical Policy Effecti ve 10/01/2021 Proprietary Information of UnitedHealthcare. Copyright 202 1 United HealthCare Services, Inc. UnitedHealthcareCommercia Chad Ramsey. Vice President, Policy, Ovarian Cancer Research Alliance. Vanessa Cramer. Director, Policy, Ovarian Cancer Research Alliance. Sponsored by. : Genentech, Inc.. Agenda . Setting the table: Timeline & key terms . January 6, 2020. 1. *Disclaimer: MDA and the contributing authors are not responsible for any changes, edits and redistribution of this program, and are solely responsible for the original copy only, which may be found on mda.org: . Personalized medicine . from the . patient/pin-cushion . perspective. Jessica D. Tenenbaum, PhD. Duke University. Department of Biostatistics and Bioinformatics. @jessiet1023. Direct To Consumer Genetic Testing. Cori Chandler, MPA. Sr. Manager, State & Local Campaigns – Access to Care. Genetic Testing. 2. Genetic Testing. What is it?. The testing of a person’s germline genes. This testing is typically performed using biospecimens such as blood or cells.